NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
Author(s): Lurati A | Bertani L | Marrazza M | Re KA | Bompane D | Scarpellini M
Volume: 2013
Issue: default
Year: 2013
Author(s): Lurati A | Bertani L | Marrazza M | Re KA | Bompane D | Scarpellini M Volume: 2013 Issue: default Year: 2013
Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
Author(s): Mathieu S | Couderc M | Glace B | Pereira B | Tournadre A | Dubost JJ | Soubrier M
Volume: 2013
Issue: default
Year: 2013
Author(s): Mathieu S | Couderc M | Glace B | Pereira B | Tournadre A | Dubost JJ | Soubrier M Volume: 2013 Issue: default Year: 2013
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action
Author(s): Damal K | Stoker E | Foley JF
Volume: 2013
Issue: default
Year: 2013
Author(s): Damal K | Stoker E | Foley JF Volume: 2013 Issue: default Year: 2013
Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
Author(s): Kaushik T | Yaqoob MM
Volume: 2013
Issue: default
Year: 2013
Author(s): Kaushik T | Yaqoob MM Volume: 2013 Issue: default Year: 2013
Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus
Author(s): Ideno S | Sakai K | Yunoki M | Kubota-Koketsu R | Inoue Y | Nakamura S | Yasunaga T | Okuno Y | Ikuta K
Volume: 2013
Issue: default
Year: 2013
Author(s): Ideno S | Sakai K | Yunoki M | Kubota-Koketsu R | Inoue Y | Nakamura S | Yasunaga T | Okuno Y | Ikuta K Volume: 2013 Issue: default Year: 2013
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
Author(s): Keohane C | Radia DH | Harrison CN
Volume: 2013
Issue: default
Year: 2013
Author(s): Keohane C | Radia DH | Harrison CN Volume: 2013 Issue: default Year: 2013
Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck
Author(s): Yang H | Diao LQ | Shi M | Ma R | Wang JH | Li JP | Xiao F | Xue Y | Xu M | Zhou B
Volume: 2013
Issue: default
Year: 2013
Author(s): Yang H | Diao LQ | Shi M | Ma R | Wang JH | Li JP | Xiao F | Xue Y | Xu M | Zhou B Volume: 2013 Issue: default Year: 2013
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
Author(s): Franz DN
Volume: 2013
Issue: default
Year: 2013
Author(s): Franz DN Volume: 2013 Issue: default Year: 2013
Treatment and management of myelofibrosis in the era of JAK inhibitors
Author(s): Keohane C | Radia DH | Harrison CN
Volume: 2013
Issue: default
Year: 2013
Author(s): Keohane C | Radia DH | Harrison CN Volume: 2013 Issue: default Year: 2013
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
Author(s): Pipattanaboon C | Sasaki T | Nishimura M | Setthapramote C | Pitaksajjakul P | Leaungwutiwong P | Limkittikul K | Puiprom O | Sasayama M | Chaichana P | Okabayashi T | Kurosu T | Ono K | Ramasoota P | Ikuta K
Volume: 2013
Issue: default
Year: 2013
Author(s): Pipattanaboon C | Sasaki T | Nishimura M | Setthapramote C | Pitaksajjakul P | Leaungwutiwong P | Limkittikul K | Puiprom O | Sasayama M | Chaichana P | Okabayashi T | Kurosu T | Ono K | Ramasoota P | Ikuta K Volume: 2013 Issue: default Year: 2013
Erythropoiesis stimulating agents approaches to modulate activity
Author(s): Sinclair AM
Volume: 2013
Issue: default
Year: 2013
Author(s): Sinclair AM Volume: 2013 Issue: default Year: 2013
A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
Author(s): Bennett J | Dubois C
Volume: 2013
Issue: default
Year: 2013
Author(s): Bennett J | Dubois C Volume: 2013 Issue: default Year: 2013
Tivozanib in the treatment of renal cell carcinoma
Author(s): Hepgur M | Sadeghi S | Dorff TB | Quinn DI
Volume: 2013
Issue: default
Year: 2013
Author(s): Hepgur M | Sadeghi S | Dorff TB | Quinn DI Volume: 2013 Issue: default Year: 2013
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
Author(s): Reuss R
Volume: 2013
Issue: default
Year: 2013
Author(s): Reuss R Volume: 2013 Issue: default Year: 2013
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
Author(s): Gledhill T | Bodger K
Volume: 2013
Issue: default
Year: 2013
Author(s): Gledhill T | Bodger K Volume: 2013 Issue: default Year: 2013
Hereditary angioedema: epidemiology, management, and role of icatibant
Author(s): Ghazi A | Grant JA
Volume: 2013
Issue: default
Year: 2013
Author(s): Ghazi A | Grant JA Volume: 2013 Issue: default Year: 2013
Bosutinib in the management of chronic myelogenous leukemia
Author(s): Keller-von Amsberg G | Schafhausen P
Volume: 2013
Issue: default
Year: 2013
Author(s): Keller-von Amsberg G | Schafhausen P Volume: 2013 Issue: default Year: 2013
Clinical use of crizotinib for the treatment of non-small cell lung cancer
Author(s): Roberts PJ
Volume: 2013
Issue: default
Year: 2013
Author(s): Roberts PJ Volume: 2013 Issue: default Year: 2013
Cetuximab: its unique place in head and neck cancer treatment
Author(s): Specenier P | Vermorken JB
Volume: 2013
Issue: default
Year: 2013
Author(s): Specenier P | Vermorken JB Volume: 2013 Issue: default Year: 2013
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Author(s): Benucci M | Saviola G | Manfredi M | Sarzi-Puttini P | Atzeni F
Volume: 2013
Issue: default
Year: 2013
Author(s): Benucci M | Saviola G | Manfredi M | Sarzi-Puttini P | Atzeni F Volume: 2013 Issue: default Year: 2013
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
Author(s): Ansari J | Hussain SA | Ansari A | Glaholm J
Volume: 2013
Issue: default
Year: 2013
Author(s): Ansari J | Hussain SA | Ansari A | Glaholm J Volume: 2013 Issue: default Year: 2013
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
Author(s): D'Arcangelo M | Cappuzzo F
Volume: 2013
Issue: default
Year: 2013
Author(s): D'Arcangelo M | Cappuzzo F Volume: 2013 Issue: default Year: 2013
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Author(s): Ververis K | Hiong A | Karagiannis TC | Licciardi PV
Volume: 2013
Issue: default
Year: 2013
Author(s): Ververis K | Hiong A | Karagiannis TC | Licciardi PV Volume: 2013 Issue: default Year: 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib
Author(s): Nooka A | Gleason C | Casbourne D | Lonial S
Volume: 2013
Issue: default
Year: 2013
Author(s): Nooka A | Gleason C | Casbourne D | Lonial S Volume: 2013 Issue: default Year: 2013
Treatment of hemophilia B: focus on recombinant factor IX
Author(s): Franchini M | Frattini F | Crestani S | Sissa C | Bonfanti C
Volume: 2013
Issue: default
Year: 2013
Author(s): Franchini M | Frattini F | Crestani S | Sissa C | Bonfanti C Volume: 2013 Issue: default Year: 2013
Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
Author(s): Walsh GM
Volume: 2013
Issue: default
Year: 2013
Author(s): Walsh GM Volume: 2013 Issue: default Year: 2013
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study
Author(s): Cantini F | Niccoli L | Cassara E | Kaloudi O | Nannini C
Volume: 2013
Issue: default
Year: 2013
Author(s): Cantini F | Niccoli L | Cassara E | Kaloudi O | Nannini C Volume: 2013 Issue: default Year: 2013
Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
Author(s): Orme ME | MacGilchrist KS | Mitchell S | Spurden D | Bird A
Volume: 2012
Issue: default
Year: 2012
Author(s): Orme ME | MacGilchrist KS | Mitchell S | Spurden D | Bird A Volume: 2012 Issue: default Year: 2012
Clofilium inhibits Slick and Slack potassium channels
Author(s): Tejada MA | Stolpe K | Meinild AK | Klaerke DA
Volume: 2012
Issue: default
Year: 2012
Author(s): Tejada MA | Stolpe K | Meinild AK | Klaerke DA Volume: 2012 Issue: default Year: 2012
Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
Author(s): Thorlund K | Druyts E | Aviña-Zubieta JA | Mills EJ
Volume: 2012
Issue: default
Year: 2012
Author(s): Thorlund K | Druyts E | Aviña-Zubieta JA | Mills EJ Volume: 2012 Issue: default Year: 2012
Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
Author(s): Noda M | Masrinoul P | Punkum C | Pipattanaboon C | Ramasoota P | Setthapramote C | Sasaki T | Sasayama M | Yamashita A | Kurosu T | Ikuta K | Okabayashi T
Volume: 2012
Issue: default
Year: 2012
Author(s): Noda M | Masrinoul P | Punkum C | Pipattanaboon C | Ramasoota P | Setthapramote C | Sasaki T | Sasayama M | Yamashita A | Kurosu T | Ikuta K | Okabayashi T Volume: 2012 Issue: default Year: 2012
Potential role of 124I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
Author(s): Smaldone MC | Chen DY | Yu JQ | Plimack ER
Volume: 2012
Issue: default
Year: 2012
Author(s): Smaldone MC | Chen DY | Yu JQ | Plimack ER Volume: 2012 Issue: default Year: 2012
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update
Author(s): Wojciechowski D | Vincenti F
Volume: 2012
Issue: default
Year: 2012
Author(s): Wojciechowski D | Vincenti F Volume: 2012 Issue: default Year: 2012
Role of CD44 as a marker of cancer stem cells in head and neck cancer
Author(s): Trapasso S | Allegra E
Volume: 2012
Issue: default
Year: 2012
Author(s): Trapasso S | Allegra E Volume: 2012 Issue: default Year: 2012
Clinical use of biologics in vasculitis syndromes
Author(s): Paroli M
Volume: 2012
Issue: default
Year: 2012
Author(s): Paroli M Volume: 2012 Issue: default Year: 2012
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
Author(s): D'Ambrosio R | Aghemo A | Colombo M
Volume: 2012
Issue: default
Year: 2012
Author(s): D'Ambrosio R | Aghemo A | Colombo M Volume: 2012 Issue: default Year: 2012
Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection
Author(s): Ippoliti G | D'Armini AM | Lucioni M | Marjieh M | Viganò M
Volume: 2012
Issue: default
Year: 2012
Author(s): Ippoliti G | D'Armini AM | Lucioni M | Marjieh M | Viganò M Volume: 2012 Issue: default Year: 2012
B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
Author(s): Wiesik-Szewczyk E | Olesinska M
Volume: 2012
Issue: default
Year: 2012
Author(s): Wiesik-Szewczyk E | Olesinska M Volume: 2012 Issue: default Year: 2012
First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
Author(s): Nguyen KS | Neal JW
Volume: 2012
Issue: default
Year: 2012
Author(s): Nguyen KS | Neal JW Volume: 2012 Issue: default Year: 2012
Lebrikizumab in the personalized management of asthma
Author(s): Thomson NC | Patel M | Smith AD
Volume: 2012
Issue: default
Year: 2012
Author(s): Thomson NC | Patel M | Smith AD Volume: 2012 Issue: default Year: 2012
The role of epigenetic mechanisms and processes in autoimmune disorders
Author(s): Greer JM | McCombe PA
Volume: 2012
Issue: default
Year: 2012
Author(s): Greer JM | McCombe PA Volume: 2012 Issue: default Year: 2012
Emerging role of multikinase inhibitors for refractory thyroid cancer
Author(s): Perez CA | Arango BA | Velez M | Raez LE | Santos ES
Volume: 2012
Issue: default
Year: 2012
Author(s): Perez CA | Arango BA | Velez M | Raez LE | Santos ES Volume: 2012 Issue: default Year: 2012
Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010
Author(s): Kubota-Koketsu R | Yunoki M | Okuno Y | Ikuta K
Volume: 2012
Issue: default
Year: 2012
Author(s): Kubota-Koketsu R | Yunoki M | Okuno Y | Ikuta K Volume: 2012 Issue: default Year: 2012
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Author(s): Cantini F | Niccoli L | Cassarà E | Kaloudi O | Nannini C
Volume: 2012
Issue: default
Year: 2012
Author(s): Cantini F | Niccoli L | Cassarà E | Kaloudi O | Nannini C Volume: 2012 Issue: default Year: 2012
Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
Author(s): Jones G | Darian-Smith E | Kwok M | Winzenberg T
Volume: 2012
Issue: default
Year: 2012
Author(s): Jones G | Darian-Smith E | Kwok M | Winzenberg T Volume: 2012 Issue: default Year: 2012
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
Author(s): Kekow J | Mueller-Ladner U | Schulze-Koops H
Volume: 2012
Issue: default
Year: 2012
Author(s): Kekow J | Mueller-Ladner U | Schulze-Koops H Volume: 2012 Issue: default Year: 2012
The effect of erythropoietin on normal and neoplastic cells
Author(s): Elliott S | Sinclair AM
Volume: 2012
Issue: default
Year: 2012
Author(s): Elliott S | Sinclair AM Volume: 2012 Issue: default Year: 2012
Metastatic gastric cancer – focus on targeted therapies
Author(s): Meza-Junco J | Sawyer MB
Volume: 2012
Issue: default
Year: 2012
Author(s): Meza-Junco J | Sawyer MB Volume: 2012 Issue: default Year: 2012
Ovarian cancer: emerging molecular-targeted therapies
Author(s): Sourbier C
Volume: 2012
Issue: default
Year: 2012
Author(s): Sourbier C Volume: 2012 Issue: default Year: 2012
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms
Author(s): Wilson HL
Volume: 2012
Issue: default
Year: 2012
Author(s): Wilson HL Volume: 2012 Issue: default Year: 2012
Natural killer cells: role in local tumor growth and metastasis
Author(s): Langers I | Renoux VM | Thiry M | Delvenne P | Jacobs N
Volume: 2012
Issue: default
Year: 2012
Author(s): Langers I | Renoux VM | Thiry M | Delvenne P | Jacobs N Volume: 2012 Issue: default Year: 2012
The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes
Author(s): Bolton K | Segal D | Walder K
Volume: 2012
Issue: default
Year: 2012
Author(s): Bolton K | Segal D | Walder K Volume: 2012 Issue: default Year: 2012
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Author(s): Prakash S | Rodes L | Coussa-Charley M | Tomaro-Duchesneau C
Volume: 2011
Issue: default
Year: 2011
Author(s): Prakash S | Rodes L | Coussa-Charley M | Tomaro-Duchesneau C Volume: 2011 Issue: default Year: 2011
Current neoadjuvant treatment options for HER2 positive breast cancer
Author(s): Abdel-Razeq H | Marei L
Volume: 2011
Issue: default
Year: 2011
Author(s): Abdel-Razeq H | Marei L Volume: 2011 Issue: default Year: 2011
Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions
Author(s): Almer G | Saba-Lepek M | Haj-Yahya S | Rohde E | Strunk D | Fröhlich E | Prassl R | Mangge H
Volume: 2011
Issue: default
Year: 2011
Author(s): Almer G | Saba-Lepek M | Haj-Yahya S | Rohde E | Strunk D | Fröhlich E | Prassl R | Mangge H Volume: 2011 Issue: default Year: 2011
Role of vandetanib in the management of medullary thyroid cancer
Author(s): Brassard M | Rondeau G
Volume: 2012
Issue: default
Year: 2012
Author(s): Brassard M | Rondeau G Volume: 2012 Issue: default Year: 2012
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm
Author(s): Heslet L | Nielsen JD | Nepper-Christensen S
Volume: 2012
Issue: default
Year: 2012
Author(s): Heslet L | Nielsen JD | Nepper-Christensen S Volume: 2012 Issue: default Year: 2012
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
Author(s): Hasan E | Olusi S | Al-Awadhi A | Mokaddem K | Sharma P | George S
Volume: 2012
Issue: default
Year: 2012
Author(s): Hasan E | Olusi S | Al-Awadhi A | Mokaddem K | Sharma P | George S Volume: 2012 Issue: default Year: 2012
Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-beta-lactamase-producing Klebsiella pneumoniae
Author(s): Shakib P | Ghafourian S | Zolfaghary MR | Hushmandfar R | Ranjbar R | Sadeghifard N
Volume: 2012
Issue: default
Year: 2011
Author(s): Shakib P | Ghafourian S | Zolfaghary MR | Hushmandfar R | Ranjbar R | Sadeghifard N Volume: 2012 Issue: default Year: 2011
Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Author(s): Cantini F | Niccoli L | Nannini C | Kaloudi O | Cassarà E | Susini M | Lenzetti I
Volume: 2012
Issue: default
Year: 2011
Author(s): Cantini F | Niccoli L | Nannini C | Kaloudi O | Cassarà E | Susini M | Lenzetti I Volume: 2012 Issue: default Year: 2011
Eribulin mesylate in the treatment of metastatic breast cancer
Author(s): Jain S | Cigler T
Volume: 2012
Issue: default
Year: 2012
Author(s): Jain S | Cigler T Volume: 2012 Issue: default Year: 2012
Monoclonal antibodies and Fc fragments for treating solid tumors
Author(s): Eisenbeis AM | Grau SJ
Volume: 2012
Issue: default
Year: 2012
Author(s): Eisenbeis AM | Grau SJ Volume: 2012 Issue: default Year: 2012
OnabotulinumtoxinA in the treatment of neurogenic bladder
Author(s): Gulamhusein A | Mangera A
Volume: 2012
Issue: default
Year: 2012
Author(s): Gulamhusein A | Mangera A Volume: 2012 Issue: default Year: 2012
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex
Author(s): Stephen P Myers | Joan O'Connor | J Helen Fitton | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Stephen P Myers | Joan O'Connor | J Helen Fitton | et al Volume: 2011 Issue: default Year: 2011
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
Author(s): Michael Sticherling
Volume: 2011
Issue: default
Year: 2011
Author(s): Michael Sticherling Volume: 2011 Issue: default Year: 2011
Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress
Author(s): Bibiana Garcia-Bailo | Ahmed El-Sohemy | Pierre S Haddad | et al
Volume: 2011
Issue: default
Year: 2011
Author(s): Bibiana Garcia-Bailo | Ahmed El-Sohemy | Pierre S Haddad | et al Volume: 2011 Issue: default Year: 2011
Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project
Author(s): Kylie Thaler | Divya V Chandiramani | Richard A Hansen | et al
Volume: 2009
Issue: default
Year: 2009
Author(s): Kylie Thaler | Divya V Chandiramani | Richard A Hansen | et al Volume: 2009 Issue: default Year: 2009
Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments
Author(s): Gesmar RS Segundo | Fabíola A Gomes | Karla P Fernandes | et al
Volume: 2009
Issue: default
Year: 2009
Author(s): Gesmar RS Segundo | Fabíola A Gomes | Karla P Fernandes | et al Volume: 2009 Issue: default Year: 2009
Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
Author(s): Manil Kukar | Olga Petryna | Petros Efthimiou
Volume: 2009
Issue: default
Year: 2009
Author(s): Manil Kukar | Olga Petryna | Petros Efthimiou Volume: 2009 Issue: default Year: 2009
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
Author(s): Regina P El Dib | Gregory M Pastores
Volume: 2009
Issue: default
Year: 2009
Author(s): Regina P El Dib | Gregory M Pastores Volume: 2009 Issue: default Year: 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies
Author(s): Laith Altaweel | Daniel Sweeney | Xizhong Cui | et al
Volume: 2009
Issue: default
Year: 2009
Author(s): Laith Altaweel | Daniel Sweeney | Xizhong Cui | et al Volume: 2009 Issue: default Year: 2009
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
Author(s): Bryan A Faller | Barbara Burtness
Volume: 2009
Issue: default
Year: 2009
Author(s): Bryan A Faller | Barbara Burtness Volume: 2009 Issue: default Year: 2009
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
Author(s): Jia Li | Muhammad Wasif Saif
Volume: 2009
Issue: default
Year: 2009
Author(s): Jia Li | Muhammad Wasif Saif Volume: 2009 Issue: default Year: 2009
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
Author(s): Deborah Elstein | Ari Zimran
Volume: 2009
Issue: default
Year: 2009
Author(s): Deborah Elstein | Ari Zimran Volume: 2009 Issue: default Year: 2009
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma
Author(s): Francesca Cainelli | Alfredo Vallone
Volume: 2009
Issue: default
Year: 2009
Author(s): Francesca Cainelli | Alfredo Vallone Volume: 2009 Issue: default Year: 2009
Finding a new drug and vaccine for emerging swine flu: What is the concept?
Author(s): Viroj Wiwanitkit
Volume: 2009
Issue: default
Year: 2009
Author(s): Viroj Wiwanitkit Volume: 2009 Issue: default Year: 2009
Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review
Author(s): Bernd Th Krause | Ralf Ohlinger | Annette Haase
Volume: 2009
Issue: default
Year: 2009
Author(s): Bernd Th Krause | Ralf Ohlinger | Annette Haase Volume: 2009 Issue: default Year: 2009
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID
Author(s): Claire Booth | H Bobby Gaspar
Volume: 2009
Issue: default
Year: 2009
Author(s): Claire Booth | H Bobby Gaspar Volume: 2009 Issue: default Year: 2009
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
Author(s): Junichiro Sageshima | Gaetano Ciancio | Linda Chen | George W Burke III
Volume: 2009
Issue: default
Year: 2009
Author(s): Junichiro Sageshima | Gaetano Ciancio | Linda Chen | George W Burke III Volume: 2009 Issue: default Year: 2009
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
Author(s): Jochen Schmitt | Gottfried Wozel
Volume: 2009
Issue: default
Year: 2009
Author(s): Jochen Schmitt | Gottfried Wozel Volume: 2009 Issue: default Year: 2009
HER2 breast cancer therapies: a review
Author(s): Conleth G Murphy | Shanu Modi
Volume: 2009
Issue: default
Year: 2009
Author(s): Conleth G Murphy | Shanu Modi Volume: 2009 Issue: default Year: 2009
Early stage and long term treatment of multiple sclerosis with interferon-β
Author(s): Angela Applebee | Hillel Panitch
Volume: 2009
Issue: default
Year: 2009
Author(s): Angela Applebee | Hillel Panitch Volume: 2009 Issue: default Year: 2009
Potentials and limitations of microorganisms as renal failure biotherapeutics
Author(s): Poonam Jain | Sapna Shah | Razek Coussa | Satya Prakash
Volume: 2009
Issue: default
Year: 2009
Author(s): Poonam Jain | Sapna Shah | Razek Coussa | Satya Prakash Volume: 2009 Issue: default Year: 2009
Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells
Author(s): Arvind Kumar | Tryambak D Singh | Santosh K Singh | Satya Prakash
Volume: 2009
Issue: default
Year: 2009
Author(s): Arvind Kumar | Tryambak D Singh | Santosh K Singh | Satya Prakash Volume: 2009 Issue: default Year: 2009
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
Author(s): Joseph M Tuscano | Jacob Sands
Volume: 2009
Issue: default
Year: 2009
Author(s): Joseph M Tuscano | Jacob Sands Volume: 2009 Issue: default Year: 2009
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
Author(s): Chad A Reade | Apar Kishor Ganti
Volume: 2009
Issue: default
Year: 2009
Author(s): Chad A Reade | Apar Kishor Ganti Volume: 2009 Issue: default Year: 2009
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
Author(s): Radhakrishnan Ramchandren | Charles A Schiffer
Volume: 2009
Issue: default
Year: 2009
Author(s): Radhakrishnan Ramchandren | Charles A Schiffer Volume: 2009 Issue: default Year: 2009
Infliximab in the treatment of rheumatoid arthritis
Author(s): A Perdriger
Volume: 2009
Issue: default
Year: 2009
Author(s): A Perdriger Volume: 2009 Issue: default Year: 2009
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
Author(s): Irina Petrache | Joud Hajjar | Michael Campos
Volume: 2009
Issue: default
Year: 2009
Author(s): Irina Petrache | Joud Hajjar | Michael Campos Volume: 2009 Issue: default Year: 2009
Long-term pegylated interferon-α and its potential in the treatment of melanoma
Author(s): Reinhard Dummer | Joanna Mangana
Volume: 2009
Issue: default
Year: 2009
Author(s): Reinhard Dummer | Joanna Mangana Volume: 2009 Issue: default Year: 2009
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Author(s): Lawrence Rice
Volume: 2009
Issue: default
Year: 2009
Author(s): Lawrence Rice Volume: 2009 Issue: default Year: 2009
Management of chronic hepatitis C treatment failures: role of consensus interferon
Author(s): Stevan A Gonzalez | Emmet B Keeffe
Volume: 2009
Issue: default
Year: 2009
Author(s): Stevan A Gonzalez | Emmet B Keeffe Volume: 2009 Issue: default Year: 2009
Challenges in the management of juvenile idiopathic arthritis with etanercept
Author(s): Clare E Pain | Liza J McCann
Volume: 2009
Issue: default
Year: 2009
Author(s): Clare E Pain | Liza J McCann Volume: 2009 Issue: default Year: 2009
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
Author(s): Steven Pipe
Volume: 2009
Issue: default
Year: 2009
Author(s): Steven Pipe Volume: 2009 Issue: default Year: 2009
Biologic targeting in the treatment of inflammatory bowel diseases
Author(s): Matteo Bosani | Sandro Ardizzone | Gabriele Bianchi Porro
Volume: 2009
Issue: default
Year: 2009
Author(s): Matteo Bosani | Sandro Ardizzone | Gabriele Bianchi Porro Volume: 2009 Issue: default Year: 2009
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
Author(s): Caitriona McLean | Catherine M Greene | Noel G McElvaney
Volume: 2009
Issue: default
Year: 2009
Author(s): Caitriona McLean | Catherine M Greene | Noel G McElvaney Volume: 2009 Issue: default Year: 2009
Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
Author(s): Martina Koch | Thomas Becker | Rainer Lueck | Michael Neipp | Juergen Klempnauer | Bjoern Nashan
Volume: 2009
Issue: default
Year: 2009
Author(s): Martina Koch | Thomas Becker | Rainer Lueck | Michael Neipp | Juergen Klempnauer | Bjoern Nashan Volume: 2009 Issue: default Year: 2009
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
Author(s): Eric Cheung | Howard A Liebman
Volume: 2009
Issue: default
Year: 2009
Author(s): Eric Cheung | Howard A Liebman Volume: 2009 Issue: default Year: 2009
Maintenance treatment with infliximab for the management of Crohn’s disease in adults
Author(s): Renato Caviglia | Ivo Boškoski | Michele Cicala
Volume: 2009
Issue: default
Year: 2009
Author(s): Renato Caviglia | Ivo Boškoski | Michele Cicala Volume: 2009 Issue: default Year: 2009
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model
Author(s): Markus Scholz | Manuela Ackermann | Frank Emmrich | Markus Loeffler | Manja Kamprad
Volume: 2009
Issue: default
Year: 2008
Author(s): Markus Scholz | Manuela Ackermann | Frank Emmrich | Markus Loeffler | Manja Kamprad Volume: 2009 Issue: default Year: 2008
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
Author(s): Bernadette Biondi | Melania Pulcrano | Loredana Pagano | Gaetano Lombardi
Volume: 2009
Issue: default
Year: 2008
Author(s): Bernadette Biondi | Melania Pulcrano | Loredana Pagano | Gaetano Lombardi Volume: 2009 Issue: default Year: 2008
Front line treatment of elderly multiple myeloma in the era of novel agents
Author(s): Marie-Dominique Venon | Aldo M Roccaro | Julie Gay | Anne-Sophie Moreau | Remy Dulery | et al
Volume: 2009
Issue: default
Year: 2008
Author(s): Marie-Dominique Venon | Aldo M Roccaro | Julie Gay | Anne-Sophie Moreau | Remy Dulery | et al Volume: 2009 Issue: default Year: 2008
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
Author(s): Aruna Chandran | Sean Fitzwater | Anjie Zhen | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Aruna Chandran | Sean Fitzwater | Anjie Zhen | et al Volume: 2010 Issue: default Year: 2010
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent
Author(s): Peter Reimer | Rolf Vosshenrich
Volume: 2010
Issue: default
Year: 2010
Author(s): Peter Reimer | Rolf Vosshenrich Volume: 2010 Issue: default Year: 2010
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
Author(s): Darja Kanduc
Volume: 2010
Issue: default
Year: 2010
Author(s): Darja Kanduc Volume: 2010 Issue: default Year: 2010
Proteasome inhibition and its therapeutic potential in multiple myeloma
Author(s): Ajai Chari | Amitabha Mazumder | Sundar Jagannath
Volume: 2010
Issue: default
Year: 2010
Author(s): Ajai Chari | Amitabha Mazumder | Sundar Jagannath Volume: 2010 Issue: default Year: 2010
Bevacizumab in the treatment of ovarian cancer
Author(s): Ramez N Eskander | Leslie M Randall
Volume: 2011
Issue: default
Year: 2011
Author(s): Ramez N Eskander | Leslie M Randall Volume: 2011 Issue: default Year: 2011
The role of stem cells in tumor targeting and growth suppression of gliomas
Author(s): Eskandary H | Basiri M | Nematollahi-Mahani SN | Mehravaran S
Volume: 2011
Issue: default
Year: 2011
Author(s): Eskandary H | Basiri M | Nematollahi-Mahani SN | Mehravaran S Volume: 2011 Issue: default Year: 2011
An update on belimumab for the treatment of lupus
Author(s): Aikaterini Thanou-Stavraki | Amr H Sawalha
Volume: 2011
Issue: default
Year: 2011
Author(s): Aikaterini Thanou-Stavraki | Amr H Sawalha Volume: 2011 Issue: default Year: 2011
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Author(s): Ara Metjian | Charles S Abrams
Volume: 2009
Issue: default
Year: 2009
Author(s): Ara Metjian | Charles S Abrams Volume: 2009 Issue: default Year: 2009
Targeted therapy in melanoma
Author(s): Hussein Tawbi | Neelima Nimmagadda
Volume: 2009
Issue: default
Year: 2009
Author(s): Hussein Tawbi | Neelima Nimmagadda Volume: 2009 Issue: default Year: 2009
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
Author(s): Damiano Paolicelli | Vita Direnzo | Maria Trojano
Volume: 2009
Issue: default
Year: 2009
Author(s): Damiano Paolicelli | Vita Direnzo | Maria Trojano Volume: 2009 Issue: default Year: 2009
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
Author(s): Riccardo Masetti | Andrea Pession
Volume: 2009
Issue: default
Year: 2009
Author(s): Riccardo Masetti | Andrea Pession Volume: 2009 Issue: default Year: 2009
The old and new therapeutic approaches to the treatment of giardiasis: Where are we?
Author(s): Haendel GNO Busatti | Joseph FG Santos | Maria A Gomes
Volume: 2009
Issue: default
Year: 2009
Author(s): Haendel GNO Busatti | Joseph FG Santos | Maria A Gomes Volume: 2009 Issue: default Year: 2009
Palifermin for management of treatment-induced oral mucositis in cancer patients
Author(s): Andrei Barasch | Joel Epstein | Ken Tilashalski
Volume: 2009
Issue: default
Year: 2009
Author(s): Andrei Barasch | Joel Epstein | Ken Tilashalski Volume: 2009 Issue: default Year: 2009
Current available therapies and future directions in the treatment of malignant gliomas
Author(s): Annick Desjardins | David A Reardon | James J Vredenburgh
Volume: 2009
Issue: default
Year: 2008
Author(s): Annick Desjardins | David A Reardon | James J Vredenburgh Volume: 2009 Issue: default Year: 2008
Botulinum toxin type A in the treatment of patients with cervical dystonia
Author(s): Allison Brashear
Volume: 2009
Issue: default
Year: 2008
Author(s): Allison Brashear Volume: 2009 Issue: default Year: 2008
Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib
Author(s): Chris Coppin
Volume: 2010
Issue: default
Year: 2010
Author(s): Chris Coppin Volume: 2010 Issue: default Year: 2010
Management of patients with advanced non-small cell lung cancer: role of gefitinib
Author(s): Vamsidhar Velcheti | Daniel Morgensztern | Ramaswamy Govindan
Volume: 2010
Issue: default
Year: 2010
Author(s): Vamsidhar Velcheti | Daniel Morgensztern | Ramaswamy Govindan Volume: 2010 Issue: default Year: 2010
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Author(s): Rosalia Ricco | Darja Kanduc
Volume: 2010
Issue: default
Year: 2010
Author(s): Rosalia Ricco | Darja Kanduc Volume: 2010 Issue: default Year: 2010
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
Author(s): Andreas Rank | Oliver Weigert | Helmut Ostermann
Volume: 2010
Issue: default
Year: 2010
Author(s): Andreas Rank | Oliver Weigert | Helmut Ostermann Volume: 2010 Issue: default Year: 2010
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
Author(s): Ori Toker | Philip J Hashkes
Volume: 2010
Issue: default
Year: 2010
Author(s): Ori Toker | Philip J Hashkes Volume: 2010 Issue: default Year: 2010
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Author(s): Santo Raffaele Mercuri | Luigi Naldi
Volume: 2010
Issue: default
Year: 2010
Author(s): Santo Raffaele Mercuri | Luigi Naldi Volume: 2010 Issue: default Year: 2010
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
Author(s): Mohamedtaki A Tejani | Roger B Cohen | Ranee Mehra
Volume: 2010
Issue: default
Year: 2010
Author(s): Mohamedtaki A Tejani | Roger B Cohen | Ranee Mehra Volume: 2010 Issue: default Year: 2010
Use of clofarabine for acute childhood leukemia
Author(s): A Pession | R Masetti | K Kleinschmidt | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): A Pession | R Masetti | K Kleinschmidt | et al Volume: 2010 Issue: default Year: 2010
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies
Author(s): Yuan Li | Janine A Burns | Carol A Cheney | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Yuan Li | Janine A Burns | Carol A Cheney | et al Volume: 2010 Issue: default Year: 2010
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
Author(s): J Paul Frindik | Stephen F Kemp
Volume: 2010
Issue: default
Year: 2010
Author(s): J Paul Frindik | Stephen F Kemp Volume: 2010 Issue: default Year: 2010
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
Author(s): Cary O Harding
Volume: 2010
Issue: default
Year: 2010
Author(s): Cary O Harding Volume: 2010 Issue: default Year: 2010
New and emerging treatment approaches to lupus
Author(s): Marion Haubitz
Volume: 2010
Issue: default
Year: 2010
Author(s): Marion Haubitz Volume: 2010 Issue: default Year: 2010
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
Author(s): William Boland | Gwyn Bebb
Volume: 2010
Issue: default
Year: 2010
Author(s): William Boland | Gwyn Bebb Volume: 2010 Issue: default Year: 2010
Safety of etanercept in elderly subjects with rheumatoid arthritis
Author(s): Alfredomaria Lurati | Mariagrazia Marrazza | Katia Angela | et al
Volume: 2010
Issue: default
Year: 2009
Author(s): Alfredomaria Lurati | Mariagrazia Marrazza | Katia Angela | et al Volume: 2010 Issue: default Year: 2009
Ustekinumab in the therapy of chronic plaque psoriasis
Author(s): Jenna L O’Neill | Robert E Kalb
Volume: 2009
Issue: default
Year: 2009
Author(s): Jenna L O’Neill | Robert E Kalb Volume: 2009 Issue: default Year: 2009
A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis
Author(s): Stephen P Myers | Joan O’Connor | J Helen Fitton | et al.
Volume: 2010
Issue: default
Year: 2010
Author(s): Stephen P Myers | Joan O’Connor | J Helen Fitton | et al. Volume: 2010 Issue: default Year: 2010
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Author(s): Richard Quek | Suzanne George
Volume: 2010
Issue: default
Year: 2010
Author(s): Richard Quek | Suzanne George Volume: 2010 Issue: default Year: 2010
Recombinant follitropin alfa/lutropin alfa in fertility treatment
Author(s): Ahmed Gibreel | Siladitya Bhattacharya
Volume: 2010
Issue: default
Year: 2009
Author(s): Ahmed Gibreel | Siladitya Bhattacharya Volume: 2010 Issue: default Year: 2009
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Author(s): Brent Sorenson | Kaysie Banton | Lance Augustin | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Brent Sorenson | Kaysie Banton | Lance Augustin | et al Volume: 2010 Issue: default Year: 2010
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Author(s): Jaclyn Flanigan | Hari Deshpande | Scott Gettinger
Volume: 2010
Issue: default
Year: 2010
Author(s): Jaclyn Flanigan | Hari Deshpande | Scott Gettinger Volume: 2010 Issue: default Year: 2010
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
Author(s): Mohamed Mahdi-Rogers | Yusuf A Rajabally
Volume: 2010
Issue: default
Year: 2010
Author(s): Mohamed Mahdi-Rogers | Yusuf A Rajabally Volume: 2010 Issue: default Year: 2010
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency
Author(s): Sabine Kroiss | Manuela Albisetti
Volume: 2010
Issue: default
Year: 2010
Author(s): Sabine Kroiss | Manuela Albisetti Volume: 2010 Issue: default Year: 2010
Palliative treatment of malignant ascites: profile of catumaxomab
Author(s): Lila Ammouri | Eric E Prommer
Volume: 2010
Issue: default
Year: 2010
Author(s): Lila Ammouri | Eric E Prommer Volume: 2010 Issue: default Year: 2010
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Author(s): Peter E Clark
Volume: 2010
Issue: default
Year: 2010
Author(s): Peter E Clark Volume: 2010 Issue: default Year: 2010
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Author(s): Josh Neman | Rahul Jandial
Volume: 2010
Issue: default
Year: 2010
Author(s): Josh Neman | Rahul Jandial Volume: 2010 Issue: default Year: 2010
Abatacept in difficult-to-treat juvenile idiopathic arthritis
Author(s): Jasmin B Kuemmerle-Deschner | SM Benseler
Volume: 2008
Issue: Issue 4
Year: 2009
Author(s): Jasmin B Kuemmerle-Deschner | SM Benseler Volume: 2008 Issue: Issue 4 Year: 2009
Therapeutic vaccines for malignant brain tumors
Author(s): Michael P Gustafson | Keith L Knutson | Allan B Dietz
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Michael P Gustafson | Keith L Knutson | Allan B Dietz Volume: 2008 Issue: Issue 4 Year: 2008
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
Author(s): David Kaminetzky | Kenneth B Hymes
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): David Kaminetzky | Kenneth B Hymes Volume: 2008 Issue: Issue 4 Year: 2008
Bevacizumab in the treatment of HER2-negative breast cancer
Author(s): Vito Lorusso
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Vito Lorusso Volume: 2008 Issue: Issue 4 Year: 2008
Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels
Author(s): Parmeet Kaur Manchanda | Anant Kumar | Raj K Sharma | Himanshu Goel | Rama Devi Mittal
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Parmeet Kaur Manchanda | Anant Kumar | Raj K Sharma | Himanshu Goel | Rama Devi Mittal Volume: 2008 Issue: Issue 4 Year: 2008
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome
Author(s): Dominic C Chow | Anne Tasaki | Jill Ono | Bruce Shiramizu | Scott A Souza
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Dominic C Chow | Anne Tasaki | Jill Ono | Bruce Shiramizu | Scott A Souza Volume: 2008 Issue: Issue 4 Year: 2008
Sorafenib for the treatment of unresectable hepatocellular carcinoma
Author(s): Junji Furuse
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Junji Furuse Volume: 2008 Issue: Issue 4 Year: 2008
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Author(s): Fernando C Fervenza | Roser Torra | David G Warnock
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Fernando C Fervenza | Roser Torra | David G Warnock Volume: 2008 Issue: Issue 4 Year: 2008
Efalizumab-induced severe thrombocytopenia can be resolved
Author(s): Francesca Prignano | F Zanieri | S Mokhtarzadeh | T Lotti
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Francesca Prignano | F Zanieri | S Mokhtarzadeh | T Lotti Volume: 2008 Issue: Issue 4 Year: 2008
Rituximab therapy in Greek patients with rheumatoid arthritis
Author(s): Aristotelis P Tsiakalos | Nestor K Avgoustidis | Haralampos M Moutsopoulos
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Aristotelis P Tsiakalos | Nestor K Avgoustidis | Haralampos M Moutsopoulos Volume: 2008 Issue: Issue 4 Year: 2008
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy
Author(s): Maristella D’Uva | Pierpaolo Di Micco | Ida Strina | Antonio Ranieri | Carlo Alviggi | et al
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Maristella D’Uva | Pierpaolo Di Micco | Ida Strina | Antonio Ranieri | Carlo Alviggi | et al Volume: 2008 Issue: Issue 4 Year: 2008
Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
Author(s): Leigh D Church | Sinisa Savic | Michael F McDermott
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Leigh D Church | Sinisa Savic | Michael F McDermott Volume: 2008 Issue: Issue 4 Year: 2008
Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies
Author(s): Steven J Greco | Pranela Rameshwar
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Steven J Greco | Pranela Rameshwar Volume: 2008 Issue: Issue 4 Year: 2008
Small molecule tyrosine kinase inhibitors in pancreatic cancer
Author(s): Sachin Gupta | Bassel F El-Rayes
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Sachin Gupta | Bassel F El-Rayes Volume: 2008 Issue: Issue 4 Year: 2008
Review of consensus interferon in the treatment of chronic hepatitis C
Author(s): Th Witthöft
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Th Witthöft Volume: 2008 Issue: Issue 4 Year: 2008
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
Author(s): Hubert Marotte | Pierre Miossec
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Hubert Marotte | Pierre Miossec Volume: 2008 Issue: Issue 4 Year: 2008
α-L-iduronidase therapy for mucopolysaccharidosis type I
Author(s): Jakub Tolar | Paul J Orchard
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Jakub Tolar | Paul J Orchard Volume: 2008 Issue: Issue 4 Year: 2008
Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation
Author(s): Yunbo Ke | R John Solaro
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Yunbo Ke | R John Solaro Volume: 2008 Issue: Issue 4 Year: 2008
Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines
Author(s): Faten Merhi | Jacques Auger | Francine Rendu | Brigitte Bauvois
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Faten Merhi | Jacques Auger | Francine Rendu | Brigitte Bauvois Volume: 2008 Issue: Issue 4 Year: 2008
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation
Author(s): Raj Kumar | William J Calhoun
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Raj Kumar | William J Calhoun Volume: 2008 Issue: Issue 4 Year: 2008
Biological drugs targeting the immune response in the therapy of psoriasis
Author(s): Saveria Pastore | Emanuela Gubinelli | Luca Leoni | Desanka Raskovic | Liudmila Korkina
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Saveria Pastore | Emanuela Gubinelli | Luca Leoni | Desanka Raskovic | Liudmila Korkina Volume: 2008 Issue: Issue 4 Year: 2008
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
Author(s): Camillo Porta | Chiara Paglino | Luciano Mutti
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Camillo Porta | Chiara Paglino | Luciano Mutti Volume: 2008 Issue: Issue 4 Year: 2008
Clinical use of topical thrombin as a surgical hemostat
Author(s): Wesley K Lew | Fred A Weaver
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Wesley K Lew | Fred A Weaver Volume: 2008 Issue: Issue 4 Year: 2008
Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)
Author(s): Dana S Hardin
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Dana S Hardin Volume: 2008 Issue: Issue 4 Year: 2008
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer
Author(s): Masahide Matsuyama | Rikio Yoshimura
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Masahide Matsuyama | Rikio Yoshimura Volume: 2008 Issue: Issue 4 Year: 2008
Anticomplement therapy
Author(s): Prathit A Kulkarni | Vahid Afshar-Kharghan
Volume: 2008
Issue: Issue 4
Year: 2009
Author(s): Prathit A Kulkarni | Vahid Afshar-Kharghan Volume: 2008 Issue: Issue 4 Year: 2009
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
Author(s): Tacjana Pressler
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Tacjana Pressler Volume: 2008 Issue: Issue 4 Year: 2008
Novel microtubule-targeting agents – the epothilones
Author(s): Kit L Cheng | Thomas Bradley | Daniel R Budman
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Kit L Cheng | Thomas Bradley | Daniel R Budman Volume: 2008 Issue: Issue 4 Year: 2008
Rituximab in the treatment of non-Hodgkin’s lymphoma
Author(s): Beate Hauptrock | Georg Hess
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Beate Hauptrock | Georg Hess Volume: 2008 Issue: Issue 4 Year: 2008
The insulin-like growth factor system and its receptors: A potential novel anticancer target
Author(s): Colin R. Lindsay | T R Jeffry Evans
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Colin R. Lindsay | T R Jeffry Evans Volume: 2008 Issue: Issue 4 Year: 2008
Adalimumab for the treatment of Crohn’s disease
Author(s): Andrea Cassinotti | Sandro Ardizzone | Gabriele Bianchi Porro
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): Andrea Cassinotti | Sandro Ardizzone | Gabriele Bianchi Porro Volume: 2008 Issue: Issue 4 Year: 2008
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
Author(s): E Michael Lewiecki
Volume: 2008
Issue: Issue 4
Year: 2008
Author(s): E Michael Lewiecki Volume: 2008 Issue: Issue 4 Year: 2008
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
Author(s): Mathieu C Tamby | Amélie Servettaz | Nicolas Tamas | Joseph Reinbolt | Frédéric Caux | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Mathieu C Tamby | Amélie Servettaz | Nicolas Tamas | Joseph Reinbolt | Frédéric Caux | et al Volume: 2008 Issue: Issue 3 Year: 2008
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy
Author(s): R Bucciardini | M Massella | A Corpolongo | P Narciso | V Fragola | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): R Bucciardini | M Massella | A Corpolongo | P Narciso | V Fragola | et al Volume: 2008 Issue: Issue 3 Year: 2008
The antidiabetic effects of a dry powder of dietary vegetable and fruit mixtures in diabetic db/db mice
Author(s): Chung-Man Yeung | Yi Tan | Sidney Tam | Liwei Lu | King-Hung Ko | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Chung-Man Yeung | Yi Tan | Sidney Tam | Liwei Lu | King-Hung Ko | et al Volume: 2008 Issue: Issue 3 Year: 2008
Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
Author(s): Peter J O’Brien | Rajeev Ramanathan | Jonathan M Yingling | Jose Baselga | Mace L Rothenberg | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Peter J O’Brien | Rajeev Ramanathan | Jonathan M Yingling | Jose Baselga | Mace L Rothenberg | et al Volume: 2008 Issue: Issue 3 Year: 2008
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
Author(s): Eduardo Lasalvia-Prisco | Emilio Garcia-Giralt | Jesús Vázquez | Marta Aghazarian | Eduardo Lasalvia-Galante | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Eduardo Lasalvia-Prisco | Emilio Garcia-Giralt | Jesús Vázquez | Marta Aghazarian | Eduardo Lasalvia-Galante | et al Volume: 2008 Issue: Issue 3 Year: 2008
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
Author(s): Shannon Puhalla | Adam Brufsky
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Shannon Puhalla | Adam Brufsky Volume: 2008 Issue: Issue 3 Year: 2008
New treatment options in the management of IBD – focus on colony stimulating factors
Author(s): Josué Barahona-Garrido | Jesús K Yamamoto-Furusho
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Josué Barahona-Garrido | Jesús K Yamamoto-Furusho Volume: 2008 Issue: Issue 3 Year: 2008
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
Author(s): Judith E Karp | Jeffrey E Lancet
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Judith E Karp | Jeffrey E Lancet Volume: 2008 Issue: Issue 3 Year: 2008
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
Author(s): Lina Nordquist | Fredrik Palm | Bradley T Andresen
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Lina Nordquist | Fredrik Palm | Bradley T Andresen Volume: 2008 Issue: Issue 3 Year: 2008
Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias
Author(s): Aldo M Roccaro | Irene M Ghobrial | Simona Blotta | Steven P Treon | Michele Malagola | et al
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Aldo M Roccaro | Irene M Ghobrial | Simona Blotta | Steven P Treon | Michele Malagola | et al Volume: 2008 Issue: Issue 3 Year: 2008
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses
Author(s): Willem MA Verhoeven | Siegfried Tuinier | Ineke van der Burgt
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Willem MA Verhoeven | Siegfried Tuinier | Ineke van der Burgt Volume: 2008 Issue: Issue 3 Year: 2008
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
Author(s): Neil Ghodadra | Kern Singh
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Neil Ghodadra | Kern Singh Volume: 2008 Issue: Issue 3 Year: 2008
Functional and gene expression analysis of hTERT overexpressed endothelial cells
Author(s): Haruna Takano | Satoshi Murasawa | Takayuki Asahara
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Haruna Takano | Satoshi Murasawa | Takayuki Asahara Volume: 2008 Issue: Issue 3 Year: 2008
Novel targets for immunotherapy in glomerulonephritis
Author(s): Mary H Foster
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Mary H Foster Volume: 2008 Issue: Issue 3 Year: 2008
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
Author(s): Bernard Escudier | Jan Cosaert | Sangeeta Jethwa
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Bernard Escudier | Jan Cosaert | Sangeeta Jethwa Volume: 2008 Issue: Issue 3 Year: 2008
Lepirudin in the management of patients with heparin-induced thrombocytopenia
Author(s): Sirak Petros
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Sirak Petros Volume: 2008 Issue: Issue 3 Year: 2008
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®
Author(s): Ferdin | Roelfsema | Nienke R Biermasz | Alberto M Pereira | Johannes A Romijn
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Ferdin | Roelfsema | Nienke R Biermasz | Alberto M Pereira | Johannes A Romijn Volume: 2008 Issue: Issue 3 Year: 2008
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Author(s): Asunción Mejías | Octavio Ramilo
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Asunción Mejías | Octavio Ramilo Volume: 2008 Issue: Issue 3 Year: 2008
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside
Author(s): Ana Villegas | Fernando A Gonzalez | Leopoldo Llorente | Santiago Redondo
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Ana Villegas | Fernando A Gonzalez | Leopoldo Llorente | Santiago Redondo Volume: 2008 Issue: Issue 3 Year: 2008
The role of B cells in systemic sclerosis
Author(s): Marina D Kraaij | Jacob M van Laar
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Marina D Kraaij | Jacob M van Laar Volume: 2008 Issue: Issue 3 Year: 2008
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Author(s): Satya Prakash | Aleksandra Malgorzata Urbanska
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Satya Prakash | Aleksandra Malgorzata Urbanska Volume: 2008 Issue: Issue 3 Year: 2008
Infliximab in ulcerative colitis
Author(s): Avi Levin | Oren Shibolet
Volume: 2008
Issue: Issue 3
Year: 2008
Author(s): Avi Levin | Oren Shibolet Volume: 2008 Issue: Issue 3 Year: 2008
Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses
Author(s): Yong-Hong Yi | Wen-Chao Guo | Wei-Wen Sun | Tao Su | Han Lin | et al
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Yong-Hong Yi | Wen-Chao Guo | Wei-Wen Sun | Tao Su | Han Lin | et al Volume: 2008 Issue: Issue 2 Year: 2008
Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition
Author(s): Bostjan Humar | Les McNoe | Anita Dunbier | Rosemary Heathcott | Antony W Braithwaite | Anthony E Reeve
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Bostjan Humar | Les McNoe | Anita Dunbier | Rosemary Heathcott | Antony W Braithwaite | Anthony E Reeve Volume: 2008 Issue: Issue 2 Year: 2008
Cognitive performance and the thymus among HIV-infected subjects receiving HAART
Author(s): Maria J Miguez-Burbano | John E Lewis | Jose Moreno | Joel Fishman
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Maria J Miguez-Burbano | John E Lewis | Jose Moreno | Joel Fishman Volume: 2008 Issue: Issue 2 Year: 2008
Natalizumab in the treatment of Crohn’s disease
Author(s): Danila Guagnozzi | Renzo Caprilli
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Danila Guagnozzi | Renzo Caprilli Volume: 2008 Issue: Issue 2 Year: 2008
Strategies for regenerating injured axons after spinal cord injury – insights from brain development
Author(s): Masaki Ueno | Toshihide Yamashita
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Masaki Ueno | Toshihide Yamashita Volume: 2008 Issue: Issue 2 Year: 2008
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences
Author(s): Matthew L Stoll | Alisa C Gotte
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Matthew L Stoll | Alisa C Gotte Volume: 2008 Issue: Issue 2 Year: 2008
Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents
Author(s): Antonio M Risitano | Bruno Rotoli
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Antonio M Risitano | Bruno Rotoli Volume: 2008 Issue: Issue 2 Year: 2008
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance
Author(s): Jennifer S Carew | Steffan T Nawrocki | Francis J Giles | John L Cleveland
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Jennifer S Carew | Steffan T Nawrocki | Francis J Giles | John L Cleveland Volume: 2008 Issue: Issue 2 Year: 2008
Natalizumab for the treatment of relapsing multiple sclerosis
Author(s): Richard A Rudick | Michael A Panzara
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Richard A Rudick | Michael A Panzara Volume: 2008 Issue: Issue 2 Year: 2008
The role of basiliximab in the evolving renal transplantation immunosuppression protocol
Author(s): Paola Salis | Chiara Caccamo | Roberto Verzaro | Salvatore Gruttadauria | Mary Artero
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Paola Salis | Chiara Caccamo | Roberto Verzaro | Salvatore Gruttadauria | Mary Artero Volume: 2008 Issue: Issue 2 Year: 2008
Update on the use of etanercept across a spectrum of rheumatoid disorders
Author(s): Bernard Combe
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Bernard Combe Volume: 2008 Issue: Issue 2 Year: 2008
Mycophenolate mofetil in the treatment of lupus nephritis
Author(s): Patrick FK Yong | David P D’Cruz
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Patrick FK Yong | David P D’Cruz Volume: 2008 Issue: Issue 2 Year: 2008
Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
Author(s): Paul N Knoebl
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): Paul N Knoebl Volume: 2008 Issue: Issue 2 Year: 2008
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
Author(s): George P Kim | Axel Grothey
Volume: 2008
Issue: Issue 2
Year: 2008
Author(s): George P Kim | Axel Grothey Volume: 2008 Issue: Issue 2 Year: 2008
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Author(s): Terry Golombick | Terry Diamond
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Terry Golombick | Terry Diamond Volume: 2008 Issue: Issue 1 Year: 2008
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
Author(s): Torsten Hans Schroeder | Wolfgang Artur Krueger | Hans-Jürgen Dieterich | Boris Nohé
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Torsten Hans Schroeder | Wolfgang Artur Krueger | Hans-Jürgen Dieterich | Boris Nohé Volume: 2008 Issue: Issue 1 Year: 2008
Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
Author(s): Greg Hodge | Stephen Davis | Michael Rice | Heather Tapp | Ben Saxon | Tamas Revesz
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Greg Hodge | Stephen Davis | Michael Rice | Heather Tapp | Ben Saxon | Tamas Revesz Volume: 2008 Issue: Issue 1 Year: 2008
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Author(s): Andrea Pession | Fraia Melchionda | Claudia Castellini
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Andrea Pession | Fraia Melchionda | Claudia Castellini Volume: 2008 Issue: Issue 1 Year: 2008
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007
Author(s): David A Schwartz
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): David A Schwartz Volume: 2008 Issue: Issue 1 Year: 2008
Infliximab for the treatment of plaque psoriasis
Author(s): Jennifer S Gall | Robert E Kalb
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Jennifer S Gall | Robert E Kalb Volume: 2008 Issue: Issue 1 Year: 2008
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Author(s): Archana Monie | Chien-Fu Hung | Richard Roden | T-C Wu
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Archana Monie | Chien-Fu Hung | Richard Roden | T-C Wu Volume: 2008 Issue: Issue 1 Year: 2008
Sunitinib for advanced renal cell cancer
Author(s): Chris Coppin
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Chris Coppin Volume: 2008 Issue: Issue 1 Year: 2008
Erlotinib in the treatment of advanced pancreatic cancer
Author(s): Robin K Kelley | Andrew H Ko
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Robin K Kelley | Andrew H Ko Volume: 2008 Issue: Issue 1 Year: 2008
Review of tocilizumab in the treatment of rheumatoid arthritis
Author(s): Yasuaki Okuda
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Yasuaki Okuda Volume: 2008 Issue: Issue 1 Year: 2008
Current and future applications of the anti-IgE antibody omalizumab
Author(s): Cristoforo Incorvaia | Marina Mauro | Gian Galeazzo Riario-Sforza | Franco Frati | Francesco Tarantini | Maurizio Caserini
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Cristoforo Incorvaia | Marina Mauro | Gian Galeazzo Riario-Sforza | Franco Frati | Francesco Tarantini | Maurizio Caserini Volume: 2008 Issue: Issue 1 Year: 2008
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Author(s): Bella Kaufman | Steven Stein | Michelle A Casey | Beth O Newstat
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Bella Kaufman | Steven Stein | Michelle A Casey | Beth O Newstat Volume: 2008 Issue: Issue 1 Year: 2008
Bevacizumab in the therapy for refractory metastatic colorectal cancer
Author(s): Mary F Mulcahy
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Mary F Mulcahy Volume: 2008 Issue: Issue 1 Year: 2008
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Author(s): Marco Montillo | Francesca Ricci | Sara Miqueleiz | Alessandra Tedeschi | Enrica Morra
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Marco Montillo | Francesca Ricci | Sara Miqueleiz | Alessandra Tedeschi | Enrica Morra Volume: 2008 Issue: Issue 1 Year: 2008
Abciximab: a reappraisal of its use in coronary care
Author(s): Marco Valgimigli | Gianluca Campo | Matteo Tebaldi | Roberto Carletti | Chiara Arcozzi | et al
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Marco Valgimigli | Gianluca Campo | Matteo Tebaldi | Roberto Carletti | Chiara Arcozzi | et al Volume: 2008 Issue: Issue 1 Year: 2008
Clinical uses of GM-CSF, a critical appraisal and update
Author(s): Martha Arellano | Sagar Lonial
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Martha Arellano | Sagar Lonial Volume: 2008 Issue: Issue 1 Year: 2008
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Author(s): Robert C Fang | Robert D Galiano
Volume: 2008
Issue: Issue 1
Year: 2008
Author(s): Robert C Fang | Robert D Galiano Volume: 2008 Issue: Issue 1 Year: 2008
